Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neuronal nitric oxide synthase (nNOS) signaling complex is a specialized protein assembly located at the postsynaptic density of neurons, primarily composed of nNOS, the scaffolding protein PSD-95, and the N-methyl-D-aspartate (NMDA) receptor (UniProt P29475, P78352). This complex couples the influx of calcium through NMDA receptors directly to the activation of nNOS, leading to the production of nitric oxide (NO), a key gaseous signaling molecule (PubMed: 12399592). While this pathway is essential for physiological processes such as synaptic plasticity and memory formation, its overactivation during ischemic stroke or traumatic brain injury leads to excessive NO production and subsequent neuronal death via excitotoxicity (PubMed: 20729862). Therapeutic intervention focuses on disrupting the protein-protein interaction between nNOS and PSD-95, which decouples the toxic signaling pathway without blocking the essential ionotropic functions of the NMDA receptor or the catalytic activity of nNOS elsewhere. Small molecules like ZL006 and peptides like Nerinetide are designed to target this interaction to provide neuroprotection in acute neurological conditions (PubMed: 32075883). This approach represents a significant advancement in neuropharmacology by targeting specific signaling sub-compartments rather than global enzyme or receptor activity.
Disruption of the protein-protein interaction (PPI) between neuronal nitric oxide synthase (nNOS) and postsynaptic density protein 95 (PSD-95) or between PSD-95 and the NMDA receptor to prevent excitotoxic nitric oxide production.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal nitric oxide synthase signaling complex (nNOS-PSD-95 complex) (nNOS-PSD-95 complex).